Characteristics and Trends in Hypnotics Consumption in the Largest Health Care System in Israel

Abstract

Objectives. To quantify and characterize hypnotics consumption habits among adult patients insured by Clalit Health Services (CHS), the largest health care provider in Israel, in 2000 and 2010. Methods. A retrospective analysis of CHS computerized pharmacy records. Data were collected for all patients over the age of 18 years who were prescribed hypnotics in 2000 and in 2010. Results. Sleep medications were consumed by 8.7% of the adult CHS population in 2000 and by 9.6% in 2010. About one-quarter of consumers were treated for more than 6 months in both years. Multiple sleeping drugs were consumed more often in 2010 (45.2%) than a decade before (22%). While in 2000 benzodiazepines accounted for 84.5% of hypnotics, in 2010 this was reduced to 73.7% (p < 0.05). Of all patients treated for longer than 6 months only 11% in 2000 and 9% in 2010 required a dose escalation suggesting the absence of tolerance. Conclusions. Nine percent of the Israeli population consumes hypnotics. There is a major increase in prescription of combination of medications between 2000 and 2010, with an increase in Z class medications use and reduction in benzodiazepines. Most patients chronically treated did not escalate dosage, suggesting the absence of tolerance.

Healthcare utilization disparities among children in Israel: big data analyses study

“…Similarly, we have previously reported that the Arab population is behind the Jewish one in diagnosing and treating obstructive sleep apnea [28]. We also showed that the Arab population consumes signi cantly fewer sleep medications than the Jewish population [29]. This can be explained by poverty, less health knowledge, and ethnicitybased factors, as discussed below.…”

Quality of Sleep among Portuguese Anaesthesiologists: A Cross-Sectional Study

“…This is higher than the prevalence in the general population, for instance in Canada (5.5%), 33 Norway (7.9%) 34 or Israel (8.7%). 35 When asked to specify, 87.3% of our population answered benzodiazepines as the medicine of choice, contrasting with 67.1% in Norway. 34 According to the Portuguese Directorate-General of Health, 36 Portugal is the EU country with the highest consumption of this pharmacological class per inhabitant.…”

Epidemic Use of Benzodiazepines among Older Adults in Israel: Epidemiology and Leverage Points for Improvement

“…Our results and those of another recent study suggest that the use of benzodiazepine/BDZRAs is substantially higher in Israel than in most other Western countries. 22 In the United Overall rate of benzodiazepine/BDZRA use among older adults in 2014 was 32%, and overall rate of heavy use (6 or more dispensings) was 19% *Reference group is patients without each of these conditions or medications…”